17 results
DEFA14A
FGEN
FibroGen Inc
31 May 23
Additional proxy soliciting materials
9:00am
Goals and 28% of our STI Goals Relate to Overlapping Pamrevlumab Goals.
We want to clarify and emphasize to shareholders that only a small minority
10-K
d7cdims18
26 Mar 15
Annual report
12:00am
S-1
EX-10.8
5bju5oby
1 Oct 14
IPO registration
12:00am
S-1
07tidx0zdo
1 Oct 14
IPO registration
12:00am
DRS/A
jrnr9eo
4 Sep 14
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next